Pharmacoeconomic Evaluation of a Pharmacist-Managed Hypertension Clinic
Article first published online: 17 JAN 2012
2001 Pharmacotherapy Publications Inc.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Volume 21, Issue 11, pages 1337–1344, November 2001
How to Cite
Okamoto, M. P. and Nakahiro, R. K. (2001), Pharmacoeconomic Evaluation of a Pharmacist-Managed Hypertension Clinic. Pharmacotherapy, 21: 1337–1344. doi: 10.1592/phco.21.17.1337.34424
- Issue published online: 17 JAN 2012
- Article first published online: 17 JAN 2012
Study Objective. To measure clinical, economic, and humanistic outcomes associated with a pharmacist-managed hypertension clinic compared with physician-managed clinics.
Design. Prospective, randomized, comparative study.
Setting. Managed care organization.
Patients. A total of 330 patients with mild-to-moderate essential hypertension.
Intervention. Hypertension care provided by either the pharmacist-managed hypertension clinic or physician-managed general medical clinics.
Measurements and Main Results. Baseline and 6-month evaluations consisted of systolic and diastolic blood pressure measurements, a short-form health survey, and collection of health care utilization information. After treatment, blood pressure measurements were significantly lower (p<0.001) in the pharmacist-managed hypertension clinic group than in the physician-managed clinic group. Patient satisfaction was significantly higher in the hypertension clinic group. Total costs for the hypertension clinic group were not different from those of the physician-managed clinic group ($242.46 vs $233.20, p=0.71), but cost:effectiveness ratios were lower in the hypertension clinic group ($27 vs $193/mm Hg for systolic blood pressure readings, and $48 vs $151/mm Hg for diastolic blood pressure readings).
Conclusion. In a hypertension clinic, pharmacists can be a cost-effective alternative to physicians in management of patients, and they can improve clinical outcomes and patient satisfaction.